alendronate has been researched along with Hepatitis C, Chronic in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, WH | 1 |
| Yu, MC | 1 |
| Huang, JY | 1 |
| Lai, PC | 1 |
| Soejima, M | 1 |
| Kawaguchi, Y | 1 |
| Hara, M | 1 |
| Saito, S | 1 |
| Kamatani, N | 1 |
| Yamanaka, H | 1 |
2 other studies available for alendronate and Hepatitis C, Chronic
| Article | Year |
|---|---|
Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients.
Topics: Absorptiometry, Photon; Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Female; | 2013 |
Therapeutic effects of alendronate on bone erosion and atrophy in a patient with rheumatoid arthritis and hepatitis C virus infection.
Topics: Adult; Alendronate; Arthritis, Rheumatoid; Atrophy; Bone and Bones; Bone Density Conservation Agents | 2008 |